-+ 0.00%
-+ 0.00%
-+ 0.00%

Nektar Therapeutics Reports Positive Phase 2b Results for Rezpegaldesleukin in Atopic Dermatitis

Reuters·02/10/2026 12:02:28

Please log in to view news